Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
Science (New York, N.Y.)
|
September 14, 1973
Montmorillonite: electron-optical observations
N Güven
Die Pharmazie
|
May 1, 1974
Studies on gallic acid esters formed by the extraction of Paeonia peregrina Mill
K C Güven, H Koyuncuoglu, A Ulubelen, et al.
International Endodontic Journal
|
November 9, 2015
Dislodgement resistance of calcium silicate-based materials from root canals with varying thickness of dentine
Ö I Ulusoy, Y N Paltun, N Güven, et al.
Acta Haematologica
|
August 15, 2000
Thrombopoietic cytokines in patients with iron deficiency anemia with or without thrombocytosis
H Akan, N Güven, I Aydogdu, et al.
Kidney International. Supplement
|
May 1, 1996
The underlying cellular mechanism of fibrosis
H P Rodemann, A Binder, A Burger, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
October 4, 2011
The orally active melanocortin-4 receptor antagonist BL-6020/979: a promising candidate for the treatment of cancer cachexia
R Dallmann, P Weyermann, C Anklin, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
Science (New York, N.Y.)
|
September 14, 1973
Montmorillonite: electron-optical observations
N Güven
Die Pharmazie
|
May 1, 1974
Studies on gallic acid esters formed by the extraction of Paeonia peregrina Mill
K C Güven, H Koyuncuoglu, A Ulubelen, et al.
International Endodontic Journal
|
November 9, 2015
Dislodgement resistance of calcium silicate-based materials from root canals with varying thickness of dentine
Ö I Ulusoy, Y N Paltun, N Güven, et al.
Acta Haematologica
|
August 15, 2000
Thrombopoietic cytokines in patients with iron deficiency anemia with or without thrombocytosis
H Akan, N Güven, I Aydogdu, et al.
Kidney International. Supplement
|
May 1, 1996
The underlying cellular mechanism of fibrosis
H P Rodemann, A Binder, A Burger, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
October 4, 2011
The orally active melanocortin-4 receptor antagonist BL-6020/979: a promising candidate for the treatment of cancer cachexia
R Dallmann, P Weyermann, C Anklin, et al.
Page
of 1